Eyebright Medical Technology (Beijing) Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000041J5
CNY
50.81
0.2 (0.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,473.61
1,403.26
943.94
574.87
428.55
270.99
193.47
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,473.61
1,403.26
943.94
574.87
428.55
270.99
193.47
Raw Material Cost
598.85
532.46
266.83
114.95
87.73
59.22
39.86
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
320.26
290.25
200.60
120.90
106.39
62.08
52.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
23.19
20.96
9.98
2.12
0.83
0.06
0.22
Selling and Distribution Expenses
400.78
338.08
281.37
169.13
136.35
88.43
74.57
Other Expenses
-26.02
-22.03
-13.13
-6.87
-6.41
-3.88
-3.67
Total Expenditure (Excl Depreciation)
1,082.86
961.43
627.48
338.38
267.22
170.97
130.26
Operating Profit (PBDIT) excl Other Income
390.79999999999995
441.8
316.5
236.5
161.29999999999998
100
63.2
Other Income
30.77
28.14
31.13
33.26
30.78
13.93
11.51
Operating Profit (PBDIT)
564.12
601.78
425.72
317.03
227.98
141.22
96.70
Interest
23.19
20.96
9.98
2.12
0.83
0.06
0.22
Exceptional Items
-71.96
-4.23
-1.84
1.49
0.20
0.28
-2.65
Gross Profit (PBDT)
874.76
870.80
677.12
459.92
340.81
211.77
153.61
Depreciation
179.80
145.59
86.46
52.43
39.37
30.26
24.16
Profit Before Tax
289.17
431.00
327.44
263.97
187.99
111.18
69.66
Tax
48.67
44.02
41.62
36.85
20.01
14.92
3.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
268.17
388.40
303.98
232.69
171.34
96.56
66.69
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
268.17
388.40
303.98
232.69
171.34
96.56
66.69
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-27.58
-1.32
-17.93
-5.46
-3.59
-0.44
-0.93
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
240.59
387.08
286.05
227.23
167.75
96.12
65.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,788.74
2,409.50
2,129.63
1,860.19
1,673.85
1,518.10
617.56
Earnings per share (EPS)
1.4
2.05
1.6
1.23
0.91
0.51
0.35
Diluted Earnings per share
1.4
2.05
1.6
1.23
0.91
0.51
0.35
Operating Profit Margin (Excl OI)
23.99%
30.5%
32.64%
40.24%
36.83%
35.81%
31.54%
Gross Profit Margin
31.82%
41.09%
43.85%
55.04%
53.05%
52.19%
48.49%
PAT Margin
18.2%
27.68%
32.2%
40.48%
39.98%
35.63%
34.47%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 5.01% vs 48.67% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -37.85% vs 35.30% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -7.03% vs 45.36% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 10.48% vs 110.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Eyebright Medical Technology (Beijing) Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,473.61
0
1,473.61
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,473.61
0
1,473.61
Raw Material Cost
598.85
0
598.85
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
320.26
0
320.26
Power Cost
0
0
0.00
Manufacturing Expenses
23.19
0
23.19
Selling and Distribution Expenses
400.78
0
400.78
Other Expenses
-26.02
0.00
-26.02
Total Expenditure (Excl Depreciation)
1,082.86
0
1,082.86
Operating Profit (PBDIT) excl Other Income
390.75
0.00
390.75
Other Income
30.77
0
30.77
Operating Profit (PBDIT)
564.12
0
564.12
Interest
23.19
0
23.19
Exceptional Items
-71.96
0
-71.96
Gross Profit (PBDT)
874.76
0
874.76
Depreciation
179.80
0
179.80
Profit Before Tax
289.17
0
289.17
Tax
48.67
0
48.67
Provisions and contingencies
0
0
0.00
Profit After Tax
268.17
0
268.17
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
268.17
0
268.17
Share in Profit of Associates
0
0
0.00
Minority Interest
-27.58
0
-27.58
Other related items
0.00
0.00
0.00
Consolidated Net Profit
240.59
0
240.59
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,788.74
0
2,788.74
Earnings per share (EPS)
1.40
0
1.40
Diluted Earnings per share
1.40
0
1.40
Operating Profit Margin (Excl OI)
23.99%
0%
0.00
23.99%
Gross Profit Margin
31.82%
0%
0.00
31.82%
PAT Margin
18.20%
0%
0.00
18.20%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 147.36 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 5.01% vs 48.67% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 24.06 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -37.85% vs 35.30% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 53.33 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -7.03% vs 45.36% in Dec 2024

Annual - Interest
Interest 2.32 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 10.48% vs 110.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.99%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024